Tristar Wellness Solutions Inc. (TWSI) 0.1400 $TWSI
Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device
PR Newswire - Wed May 06, 7:30AM CDT
TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) a health and wellness company that targets opportunities in the advanced wound care marketplace, announced today that its Portland, Oregon based wholly owned independent subsidiary HemCon Medical Technologies, Inc. (HemCon) has been awarded funding from the National Institutes of Health (NIH) to develop a novel chitosan endoluminal hemostatic dressing that is able to be delivered by a catheter to control and prevent prostatic bleeding during prostatic surgery such as transurethral resection of the prostate (TURP). Oregon Health & Science University (OHSU) will work with HemCon as a subcontractor on development of the dressing.
HemCon Medical Technologies Launches into Chinese Market
PR Newswire - Tue Apr 07, 7:40AM CDT
TriStar Wellness Solutions, Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the advanced wound care marketplace, through its subsidiary, HemCon Medical Technologies, Inc has received regulatory approval from the China Food and Drug Administration (CFDA) to market and sell products into China. HemCon has commercially entered the market this month by accepting an order through a distributor on the mainland. HemCon's launch into the Chinese market will include its full portfolio of wound care solutions which are protected by patents both in China and throughout the world. Currently the wound care market in China is estimated at $1.2 billion.
HemCon Medical Technologies, Inc. Receives 2015 Best of Portland Award
PR Newswire - Tue Mar 24, 7:45AM CDT
HemCon Medical Technologies, Inc ("HemCon"
, a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced wound care products, today announced it received the 2015 Best of Portland Award in the Bandages & Dressing category by the Portland Award Program.
HemCon Joins aptitude LLC for Direct Contracting Value
PR Newswire - Tue Mar 17, 7:30AM CDT
HemCon Medical Technologies, Inc. ("HemCon", a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced wound care products, announced today that HemCon has joined aptitude LLC the healthcare industry's first direct contracting market. Today, aptitude has over 1,000 hospitals that benefit from reducing the online platform that reduces the contract cycle time by 50% by automating key components of the process. HemCon has added its full product line to aptitude and hopes to introduce new customers by using the user friendly interface and quick turn around on contracts. HemCon plans to continue to grow its portfolio online, which will be beneficial to all current and prospective HemCon customers. Adding an additional way to take its products to market supports HemCon's continuing expansion into the hospital market.
HemCon Medical Technologies Continues Transition to Innovation Leader
PR Newswire - Tue Feb 17, 7:40AM CST
TriStar Wellness Solutions, Inc., (OTCQB: TWSI), a health and wellness company that targets opportunities in the advanced wound care marketplace, announces several recent appointments of key personnel at its subsidiary, HemCon Medical Technologies, Inc. to complete its transition to exclusively focus the company resources on marketing and sales, new product development and technological innovations, best of class regulatory and quality systems. The company has successfully completed their physical move to new facilities in downtown Portland, Oregon and transferred all manufacturing to U.S.-based world class outsourcing partners.
HemCon Medical Technologies, Inc. Awarded Hemostasis and Compression Products Agreement With Premier, Inc.
PR Newswire - Mon Nov 03, 7:34AM CST
HemCon Medical Technologies, Inc. ("HemCon", a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today that the company has been awarded a group purchasing agreement for Hemostasis and Compression Products with Premier, Inc. effective November 1, 2014. The new agreement (PP-CA-248) allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the entire line of HemCon hemostatic products, including products such as the HemCon Patch® PRO, ideal for bleeding control following heart catheterizations, ChitoGauze® PRO for traumatic injuries and GuardaCare®XR Surgical, a must have tool for controlling bleeding and maintaining surgical field visibility in the operating room.
PINC: 38.07 (+0.05)
Ludlow Research Issues Opinion on TriStar Wellness Solutions Based on Pending Q3 Earnings, Valuation
PR Newswire - Mon Oct 20, 7:22AM CDT
TriStar Wellness Solutions®, Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced that Ludlow Research has issued a research opinion of the Company based on strong Q3 revenue guidance, and current valuation.
HemCon Medical Technologies, Inc. Projects Strong Third Quarter Revenues
PR Newswire - Tue Sep 16, 7:35AM CDT
HemCon Medical Technologies, Inc. ("HemCon", a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today that the revenue performance on their chitosan technology platform has grown by 39 percent, and microdispersed oxidized cellulose raw material is up 22 percent year-to-date though August 2014. Overall, TWSI expects third quarter revenues to surpass the prior year in excess of 50 percent and be in line with overall business expectations for 2014.
HemCon Medical Technologies, Inc. Announces Strategic Facility Relocation to Support Rapid Growth and New Product Development
PR Newswire - Wed Sep 03, 7:30AM CDT
HemCon Medical Technologies, Inc. ("HemCon", a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today that they will be exclusively focusing company resources on marketing and sales, new product development and technological innovations, best of class regulatory and quality systems and upgrading all internal information systems immediately.
HemCon Medical Technologies, Inc. Announces New Research on ChitoGauze(R) Published in Leading European Trauma Journal
PRWeb - Fri Jun 13, 7:06AM CDT
HemCon Medical Technologies, Inc. ("HemCon", a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today that Authors Dr. E.C.T.H. Tan and Dr. J. Peters have published in the Dutch Journal of TraumaSurgery encouraging results of a study conducted between 2009 and 2013 using HemCon's hemostatic chitosan-coated dressing ChitoGauze(R) on pre-hospital bleeding patients by one of the four Dutch Helicopter-Mobile Medical Teams; the Lifeliner3 of the Radboud University Medical Center, Nijmegen the Netherlands.
HemCon Medical Technologies, Inc. Announces New Research on ChitoGauze® Published in Leading European Trauma Journal
PR Newswire - Thu Jun 12, 7:00AM CDT
HemCon Medical Technologies, Inc. ("HemCon", a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today that Authors Dr. E.C.T.H. Tan and Dr. J. Peters have published in the Dutch Journal of TraumaSurgery encouraging results of a study conducted between 2009 and 2013 using HemCon's hemostatic chitosan-coated dressing ChitoGauze® on pre-hospital bleeding patients by one of the four Dutch Helicopter-Mobile Medical Teams; the Lifeliner3 of the Radboud University Medical Center, Nijmegen the Netherlands.
Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device
PR Newswire - Wed May 06, 7:30AM CDT
TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) a health and wellness company that targets opportunities in the advanced wound care marketplace, announced today that its Portland, Oregon based wholly owned independent subsidiary HemCon Medical Technologies, Inc. (HemCon) has been awarded funding from the National Institutes of Health (NIH) to develop a novel chitosan endoluminal hemostatic dressing that is able to be delivered by a catheter to control and prevent prostatic bleeding during prostatic surgery such as transurethral resection of the prostate (TURP). Oregon Health & Science University (OHSU) will work with HemCon as a subcontractor on development of the dressing.
HemCon Medical Technologies Launches into Chinese Market
PR Newswire - Tue Apr 07, 7:40AM CDT
TriStar Wellness Solutions, Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the advanced wound care marketplace, through its subsidiary, HemCon Medical Technologies, Inc has received regulatory approval from the China Food and Drug Administration (CFDA) to market and sell products into China. HemCon has commercially entered the market this month by accepting an order through a distributor on the mainland. HemCon's launch into the Chinese market will include its full portfolio of wound care solutions which are protected by patents both in China and throughout the world. Currently the wound care market in China is estimated at $1.2 billion.
HemCon Medical Technologies, Inc. Receives 2015 Best of Portland Award
PR Newswire - Tue Mar 24, 7:45AM CDT
HemCon Medical Technologies, Inc ("HemCon"
, a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced wound care products, today announced it received the 2015 Best of Portland Award in the Bandages & Dressing category by the Portland Award Program. HemCon Joins aptitude LLC for Direct Contracting Value
PR Newswire - Tue Mar 17, 7:30AM CDT
HemCon Medical Technologies, Inc. ("HemCon"
, a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced wound care products, announced today that HemCon has joined aptitude LLC the healthcare industry's first direct contracting market. Today, aptitude has over 1,000 hospitals that benefit from reducing the online platform that reduces the contract cycle time by 50% by automating key components of the process. HemCon has added its full product line to aptitude and hopes to introduce new customers by using the user friendly interface and quick turn around on contracts. HemCon plans to continue to grow its portfolio online, which will be beneficial to all current and prospective HemCon customers. Adding an additional way to take its products to market supports HemCon's continuing expansion into the hospital market. HemCon Medical Technologies Continues Transition to Innovation Leader
PR Newswire - Tue Feb 17, 7:40AM CST
TriStar Wellness Solutions, Inc., (OTCQB: TWSI), a health and wellness company that targets opportunities in the advanced wound care marketplace, announces several recent appointments of key personnel at its subsidiary, HemCon Medical Technologies, Inc. to complete its transition to exclusively focus the company resources on marketing and sales, new product development and technological innovations, best of class regulatory and quality systems. The company has successfully completed their physical move to new facilities in downtown Portland, Oregon and transferred all manufacturing to U.S.-based world class outsourcing partners.
HemCon Medical Technologies, Inc. Awarded Hemostasis and Compression Products Agreement With Premier, Inc.
PR Newswire - Mon Nov 03, 7:34AM CST
HemCon Medical Technologies, Inc. ("HemCon"
, a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today that the company has been awarded a group purchasing agreement for Hemostasis and Compression Products with Premier, Inc. effective November 1, 2014. The new agreement (PP-CA-248) allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the entire line of HemCon hemostatic products, including products such as the HemCon Patch® PRO, ideal for bleeding control following heart catheterizations, ChitoGauze® PRO for traumatic injuries and GuardaCare®XR Surgical, a must have tool for controlling bleeding and maintaining surgical field visibility in the operating room. PINC: 38.07 (+0.05)
Ludlow Research Issues Opinion on TriStar Wellness Solutions Based on Pending Q3 Earnings, Valuation
PR Newswire - Mon Oct 20, 7:22AM CDT
TriStar Wellness Solutions®, Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced that Ludlow Research has issued a research opinion of the Company based on strong Q3 revenue guidance, and current valuation.
HemCon Medical Technologies, Inc. Projects Strong Third Quarter Revenues
PR Newswire - Tue Sep 16, 7:35AM CDT
HemCon Medical Technologies, Inc. ("HemCon"
, a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today that the revenue performance on their chitosan technology platform has grown by 39 percent, and microdispersed oxidized cellulose raw material is up 22 percent year-to-date though August 2014. Overall, TWSI expects third quarter revenues to surpass the prior year in excess of 50 percent and be in line with overall business expectations for 2014. HemCon Medical Technologies, Inc. Announces Strategic Facility Relocation to Support Rapid Growth and New Product Development
PR Newswire - Wed Sep 03, 7:30AM CDT
HemCon Medical Technologies, Inc. ("HemCon"
, a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today that they will be exclusively focusing company resources on marketing and sales, new product development and technological innovations, best of class regulatory and quality systems and upgrading all internal information systems immediately. HemCon Medical Technologies, Inc. Announces New Research on ChitoGauze(R) Published in Leading European Trauma Journal
PRWeb - Fri Jun 13, 7:06AM CDT
HemCon Medical Technologies, Inc. ("HemCon"
, a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today that Authors Dr. E.C.T.H. Tan and Dr. J. Peters have published in the Dutch Journal of TraumaSurgery encouraging results of a study conducted between 2009 and 2013 using HemCon's hemostatic chitosan-coated dressing ChitoGauze(R) on pre-hospital bleeding patients by one of the four Dutch Helicopter-Mobile Medical Teams; the Lifeliner3 of the Radboud University Medical Center, Nijmegen the Netherlands. HemCon Medical Technologies, Inc. Announces New Research on ChitoGauze® Published in Leading European Trauma Journal
PR Newswire - Thu Jun 12, 7:00AM CDT
HemCon Medical Technologies, Inc. ("HemCon"
, a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today that Authors Dr. E.C.T.H. Tan and Dr. J. Peters have published in the Dutch Journal of TraumaSurgery encouraging results of a study conducted between 2009 and 2013 using HemCon's hemostatic chitosan-coated dressing ChitoGauze® on pre-hospital bleeding patients by one of the four Dutch Helicopter-Mobile Medical Teams; the Lifeliner3 of the Radboud University Medical Center, Nijmegen the Netherlands. 
